Results of tender offer announced by Elan Corporation

NewsGuard 100/100 Score

Elan Corporation, plc (NYSE:ELN) ("Elan") today announced the results as of the early tender date of the tender offer for the 7¾% Senior Fixed Rate Notes due 2011 (CUSIP No. 284138AC8) (the “Notes”) issued by its wholly-owned subsidiaries, Elan Finance public limited company and Elan Finance Corp. (the “Co-Issuers”).

As of 11:59 p.m., New York City time, on October 13, 2009, the Co-Issuers had received tenders in respect of $783.9 million aggregate principal amount of Notes, representing approximately 92.23% of the outstanding Notes, all of which have been accepted for purchase. The holders of the accepted Notes will be entitled to receive total consideration of $1,019.38 per $1,000 of principal amount tendered. The total consideration includes an early tender premium of $30.00 per $1,000 principal amount of Notes tendered.

The total cash payment to purchase the Notes, including accrued and unpaid interest up to, but not including, the early payment date, is approximately $824.3 million. Such payment is expected to be made on or about October 14, 2009. Holders who have not already tendered Notes may continue to do so at any time at or prior to 11:59 p.m. New York City time, on October 28, 2009, unless the Co-Issuers extend or earlier terminate the tender offer. However, such holders will not be entitled to receive any early tender premium, except in the case of any Notes that were tendered prior to 11:59 p.m., New York City time, on October 13, 2009, and which are ultimately accepted for purchase. Withdrawal rights for the tender offer have expired. Accordingly, holders may not withdraw any Notes previously or hereafter tendered, except as contemplated in the Co-Issuers’ Offer to Purchase dated September 29, 2009.

Source:

Elan Corporation, plc

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.